KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Regeneron Pharmaceuticals (REGN) Interest Coverage Ratio (2017 - 2025)

Regeneron Pharmaceuticals (REGN) has 16 years of Interest Coverage Ratio data on record, last reported at 72.12 in Q4 2025.

  • For Q4 2025, Interest Coverage Ratio fell 23.52% year-over-year to 72.12; the TTM value through Dec 2025 reached 81.69, up 12.99%, while the annual FY2025 figure was 81.69, 12.99% up from the prior year.
  • Interest Coverage Ratio reached 72.12 in Q4 2025 per REGN's latest filing, up from 53.2 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 299.86 in Q2 2025 and bottomed at 46.67 in Q1 2024.
  • Average Interest Coverage Ratio over 5 years is 86.08, with a median of 72.12 recorded in 2025.
  • Peak YoY movement for Interest Coverage Ratio: tumbled 43.16% in 2023, then skyrocketed 314.92% in 2025.
  • A 5-year view of Interest Coverage Ratio shows it stood at 130.08 in 2021, then plummeted by 49.33% to 65.91 in 2022, then fell by 19.34% to 53.16 in 2023, then surged by 77.38% to 94.3 in 2024, then fell by 23.52% to 72.12 in 2025.
  • Per Business Quant database, its latest 3 readings for Interest Coverage Ratio were 72.12 in Q4 2025, 53.2 in Q3 2025, and 299.86 in Q2 2025.